CureVac N.V. provided its financial results for the first quarter of 2025 along with business updates. The press release includes forward-looking statements about the company’s vaccine and treatment candidates, strategies, financing plans, cash runway expectations, regulatory approval, growth opportunities, and market growth. These statements are based on current beliefs and assumptions but are subject to […]
Tag: Cash Runway
Elicio Therapeutics Secures $10M Financing
Elicio Therapeutics has secured $10 million in financing, ensuring operational support beyond anticipated milestones. With a focus on advancing clinical programs, Elicio aims to transform cancer treatment with its product candidates. The funding paves the way for future development initiatives and potential expansion into additional indications. Forward-looking statements underscore the company’s commitment to innovation and […]
